Table 1 Baseline characteristics of AF patients with or without SCD/VAs.
Variables | With SCD/VAs (n = 14,221) | Without SCD/VAs (n = 338,435) | P value |
|---|---|---|---|
Age, years; mean value (SD) | 72.4 (12.2) | 71.3 (13.1) | <0.001 |
Age ≥75 years, n (%) | 7,038 (49.5) | 157,069 (46.4) | <0.001 |
Male gender, n (%) | 8,000 (56.3) | 187,357 (55.4) | 0.035 |
Comorbidities, n (%) | |||
Congestive heart failure | 7,291 (51.3) | 136,621 (40.4) | <0.001 |
Hypertension | 10,121 (71.2) | 231,210 (68.3) | <0.001 |
Diabetes mellitus | 4,619 (32.5) | 96,065 (28.4) | <0.001 |
Previous stroke/TIA | 5,175 (36.4) | 117,707 (34.8) | <0.001 |
Vascular diseases | 3,421 (24.1) | 76,125 (22.5) | <0.001 |
Non-ESRD CKD | 2,426 (17.1) | 51,157 (15.1) | <0.001 |
ESRD | 495 (3.5) | 7,261 (2.2) | <0.001 |
COPD | 5,368 (37.8) | 119,690 (35.4) | <0.001 |
Malignancy | 563 (4.0) | 18,857 (5.6) | <0.001 |
Autoimmune diseases | 700 (4.9) | 18,766 (5.5) | 0.001 |
Liver cirrhosis | 428 (3.0) | 11,356 (3.4) | 0.025 |
Medications, n (%) | |||
Aspirin | 4,513 (31.7) | 102,647 (30.3) | <0.001 |
Clopidogrel | 679 (4.8) | 13,882 (4.1) | <0.001 |
Warfarin | 1,664 (11.7) | 40,222 (11.9) | 0.507 |
Beta-blockers | 2,234 (15.7) | 60,050 (17.7) | <0.001 |
CCBs | 1,374 (9.7) | 30,267 (8.9) | 0.003 |
Digoxin | 3,205 (22.5) | 57,915 (17.1) | <0.001 |
Class I AADs | 427 (3.0) | 12,388 (3.7) | <0.001 |
Class III AADs | 1,359 (9.6) | 29,650 (8.8) | 0.001 |
ACEIs/ARBs | 4,344 (30.6) | 97,110 (28.7) | <0.001 |
Statins | 712 (5.0) | 13,948 (4.1) | <0.001 |
Degree of urbanization, n (%) | |||
Urban | 7,498 (52.7) | 174,095 (51.4) | 0.004 |
Suburban | 4,658 (32.8) | 112,536 (33.3) | |
Rural | 2,065 (14.5) | 51,804 (15.3) | |
Income level, n (%) | |||
Low | 7,748 (54.5) | 181,336 (53.6) | 0.031 |
Median | 4,696 (33.0) | 112,537 (33.3) | |
High | 1,777 (12.5) | 44,562 (13.2) | |
